2576 studies found for:    "Prostatic Neoplasms"
Show Display Options
Rank Status Study
1 Active, not recruiting CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
Conditions: Prostate Cancer;   Prostatic Cancer;   Prostate Neoplasms;   Prostatic Neoplasms;   Cancer of the Prostate
Intervention: Radiation: CyberKnife Stereotactic Radiosurgery
2 Active, not recruiting CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Conditions: Prostate Cancer;   Prostatic Cancer;   Prostatic Neoplasms;   Prostate Neoplasms;   Cancer of the Prostate
Intervention: Radiation: CyberKnife Stereotactic Radiosurgery
3 Recruiting A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostrate Cancer and Men With Metastatic Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Castration-resistant Prostate Cancer
Intervention:
4 Recruiting Lyophilized Black Raspberry in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions: Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: lyophilized black raspberry lozenge;   Other: laboratory biomarker analysis;   Dietary Supplement: dietary intervention;   Procedure: therapeutic conventional surgery;   Procedure: quality-of-life assessment;   Other: questionnaire administration
5 Recruiting Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: Docetaxel;   Dietary Supplement: Lycopene
6 Not yet recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Intervention: Drug: onapristone
7 Recruiting Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
Conditions: Diarrhea;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: cabazitaxel;   Drug: prednisone;   Drug: octreotide pamoate;   Other: questionnaire administration;   Drug: octreotide acetate
8 Active, not recruiting Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
Conditions: Bone Metastases;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Procedure: magnetic resonance imaging;   Radiation: fluorine F 18 sodium fluoride;   Procedure: positron emission tomography;   Procedure: computed tomography;   Radiation: technetium Tc 99m methylene diphosphonate;   Other: laboratory biomarker analysis
9 Withdrawn Atorvastatin Calcium in Preventing Metabolic Syndrome in Patients With Prostate Cancer Receiving Long-Term Androgen-Deprivation Therapy
Conditions: Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: atorvastatin calcium;   Drug: placebo
10 Recruiting Cabozantinib in Treating Men With Castration-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Castration-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis
11 Completed Cilengitide in Treating Patients With Prostate Cancer
Conditions: Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: cilengitide;   Other: laboratory biomarker analysis
12 Recruiting High-Dose Stereotactic Radiation for Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Radiation: stereotactic body radiation therapy;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
13 Recruiting Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: abiraterone;   Drug: prednisone
14 Recruiting Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Pain;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: mitoxantrone;   Drug: prednisone
15 Completed A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Cancer of the Prostate
Intervention: Drug: IPI-504
16 Recruiting A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine
Conditions: Adenocarcinoma of the Prostate;   Bone Metastases;   Soft Tissue Metastases;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Intervention: Drug: Ranolazine
17 Completed Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Biological: bevacizumab;   Other: laboratory biomarker analysis
18 Unknown  Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
Conditions: Cancer of the Prostate;   Prostate Cancer;   Prostatic Neoplasms
Interventions: Dietary Supplement: Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E;   Drug: Placebo
19 Terminated
Has Results
Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients
Conditions: Prostate Cancer;   Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: sunitinib malate;   Drug: docetaxel;   Drug: prednisone
20 Active, not recruiting Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Pain;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: prednisone

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years